p21WAF1/CIP1 promotes p53 protein degradation by facilitating p53-Wip1 and p53-Mdm2 interaction
Open Access
- 1 March 2021
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 543, 23-28
Abstract
No abstract availableKeywords
Funding Information
- National Research Foundation of Korea
This publication has 21 references indexed in Scilit:
- Deciphering p53 signaling in tumor suppressionCurrent Opinion in Cell Biology, 2018
- Role of wild-type p53-induced phosphatase 1 in cancerOncology Letters, 2017
- WIP1 phosphatase as pharmacological target in cancer therapyJournal of Molecular Medicine, 2017
- p53 and its mutants in tumor cell migration and invasionJournal of Cell Biology, 2011
- Targeting p53 for Novel Anticancer TherapyTranslational Oncology, 2010
- Mdm2-mediated ubiquitylation: p53 and beyondCell Death & Differentiation, 2009
- The type 2C phosphatase Wip1: An oncogenic regulator of tumor suppressor and DNA damage response pathwaysCancer and Metastasis Reviews, 2008
- The Wip1 phosphatase and Mdm2: Cracking the "Wip" on p53 stabilityCell Cycle, 2008
- Structure–function–rescue: the diverse nature of common p53 cancer mutantsOncogene, 2007
- AMP-Activated Protein Kinase Induces a p53-Dependent Metabolic CheckpointMolecular Cell, 2005